| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Lin Wang | |
| Xiaomin Chen | |||
| Jiatao Lou | |||
| P2860 | cites work | Electrochemical sensors and biosensors based on nanomaterials and nanostructures | Q23911041 |
| Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations | Q24678861 | ||
| Fragment Length of Circulating Tumor DNA | Q27308628 | ||
| Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients | Q28067439 | ||
| DISSECT Method Using PNA-LNA Clamp Improves Detection of EGFR T790m Mutation | Q28534155 | ||
| Origins, structures, and functions of circulating DNA in oncology | Q30249103 | ||
| Nanotechnology for enrichment and detection of circulating tumor cells. | Q30382502 | ||
| Detection of EGFR mutation in plasma using multiplex allele-specific PCR (MAS-PCR) and surface enhanced Raman spectroscopy | Q33881503 | ||
| About the possible origin and mechanism of circulating DNA apoptosis and active DNA release | Q34100424 | ||
| Detection and quantification of mutations in the plasma of patients with colorectal tumors | Q34132363 | ||
| Cell-free nucleic acids as biomarkers in cancer patients | Q34184393 | ||
| An introduction to peptide nucleic acid. | Q34320896 | ||
| Liquid biopsy: monitoring cancer-genetics in the blood | Q34356149 | ||
| PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer | Q36103228 | ||
| Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection | Q36231307 | ||
| Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood | Q36497457 | ||
| Circulating nucleic acids (CNAs) and cancer--a survey | Q36669780 | ||
| Heterogeneity and clinical significance of ESR1 mutations in ER-positive metastatic breast cancer patients receiving fulvestrant | Q36907216 | ||
| Simple, Sensitive and Accurate Multiplex Detection of Clinically Important Melanoma DNA Mutations in Circulating Tumour DNA with SERS Nanotags. | Q37112945 | ||
| Suspension arrays based on nanoparticle-encoded microspheres for high-throughput multiplexed detection | Q37575713 | ||
| Surface-enhanced Raman spectroscopy | Q37773345 | ||
| DNA methylation and its basic function | Q38025275 | ||
| Detection of the hereditary hemochromatosis gene mutation by real-time fluorescence polymerase chain reaction and peptide nucleic acid clamping | Q38335687 | ||
| Management of advanced non-small cell lung cancers with known mutations or rearrangements: latest evidence and treatment approaches | Q38653663 | ||
| Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma. | Q38694431 | ||
| Tumor exosomes: cellular postmen of cancer diagnosis and personalized therapy | Q38702636 | ||
| Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures | Q38760739 | ||
| The Long and Short of Circulating Cell-Free DNA and the Ins and Outs of Molecular Diagnostics | Q38821212 | ||
| Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer | Q38860960 | ||
| Ultra-Sensitive Detection of the Pretreatment EGFR T790M Mutation in Non-Small Cell Lung Cancer Patients with an EGFR-Activating Mutation Using Droplet Digital PCR. | Q38886040 | ||
| Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer | Q38920745 | ||
| Towards DNA methylation detection using biosensors | Q38972400 | ||
| Recent strategies toward microfluidic-based surface-enhanced Raman spectroscopy | Q39255943 | ||
| BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles. | Q40126434 | ||
| Highly Sensitive Droplet Digital PCR Method for Detection of EGFR-Activating Mutations in Plasma Cell-Free DNA from Patients with Advanced Non-Small Cell Lung Cancer | Q40263469 | ||
| Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials. | Q40454933 | ||
| Peptide nucleic acids (PNA): synthesis, properties and potential applications | Q41020618 | ||
| Quantum dots in imaging, drug delivery and sensor applications. | Q41283510 | ||
| Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer | Q41646881 | ||
| Single copy-sensitive electrochemical assay for circulating methylated DNA in clinical samples with ultrahigh specificity based on a sequential discrimination-amplification strategy. | Q41671038 | ||
| The first liquid biopsy test approved. Is it a new era of mutation testing for non-small cell lung cancer? | Q41866575 | ||
| Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma | Q45721923 | ||
| Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686). | Q46093703 | ||
| DNA Clutch Probes for Circulating Tumor DNA Analysis | Q49123121 | ||
| High-performance electrochemical sensing of circulating tumor DNA in peripheral blood based on poly-xanthurenic acid functionalized MoS2 nanosheets | Q49791505 | ||
| Femtomolar level detection of RASSF1A tumor suppressor gene methylation by electrochemical nano-genosensor based on Fe3O4/TMC/Au nanocomposite and PT-modified electrode. | Q50913138 | ||
| Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges. | Q52325243 | ||
| Surface Enhanced Raman Spectroscopy (SERS) for the Multiplex Detection of Braf, Kras, and Pik3ca Mutations in Plasma of Colorectal Cancer Patients. | Q52647654 | ||
| Comparison of the SuperARMS and Droplet Digital PCR for Detecting EGFR Mutation in ctDNA From NSCLC Patients. | Q52662547 | ||
| Validation and comparison of two NGS assays for the detection of EGFR T790M resistance mutation in liquid biopsies of NSCLC patients. | Q52803546 | ||
| Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients. | Q52879885 | ||
| Fully automated, on-site isolation of cfDNA from whole blood for cancer therapy monitoring. | Q53073698 | ||
| In situ hybridization chain reaction mediated ultrasensitive enzyme-free and conjugation-free electrochemcial genosensor for BRCA-1 gene in complex matrices. | Q53255586 | ||
| Low fouling label-free DNA sensor based on polyethylene glycols decorated with gold nanoparticles for the detection of breast cancer biomarkers. | Q53260342 | ||
| Electrochemical affinity biosensors for fast detection of gene-specific methylations with no need for bisulfite and amplification treatments. | Q55285442 | ||
| DNA Methylation and Cancer | Q57239860 | ||
| Fe-Au Nanoparticle-Coupling for Ultrasensitive Detections of Circulating Tumor DNA | Q59358313 | ||
| Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma | Q61808912 | ||
| A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue | Q82668911 | ||
| Quantitative detection of EGFR mutations in circulating tumor DNA derived from lung adenocarcinomas | Q85049473 | ||
| A dual biomarker detection platform for quantitating circulating tumor DNA (ctDNA) | Q89764960 | ||
| A dual signal amplification nanosensor based on SERS technology for detection of tumor-related DNA | Q90388903 | ||
| An ultrasensitive test for profiling circulating tumor DNA using integrated comprehensive droplet digital detection | Q91419059 | ||
| A versatile label-free electrochemical biosensor for circulating tumor DNA based on dual enzyme assisted multiple amplification strategy | Q91852382 | ||
| Liquid Biopsy: General Concepts | Q92041321 | ||
| On-chip isolation and enrichment of circulating cell-free DNA using microfluidic device | Q92175470 | ||
| Nanomaterials multifunctional behavior for enlightened cancer therapeutics | Q92662571 | ||
| Multiplexed Detection of Mutant Circulating Tumor DNA Using Peptide Nucleic Acid Clamping Asymmetric Polymerase Chain Reaction and Liquidchip | Q92728750 | ||
| "Learning on a chip:" Microfluidics for formal and informal science education | Q92736132 | ||
| Opportunities, Challenges, and Prospects in Electrochemical Biosensing of Circulating Tumor DNA and its Specific Features | Q93078977 | ||
| The Current Role of Microfluidics in Radiofluorination Chemistry | Q93112560 | ||
| Cancer diagnosis: from tumor to liquid biopsy and beyond | Q93333048 | ||
| Versatile Electroanalytical Bioplatforms for Simultaneous Determination of Cancer-Related DNA 5-Methyl- and 5-Hydroxymethyl-Cytosines at Global and Gene-Specific Levels in Human Serum and Tissues | Q93382689 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
| P921 | main subject | nanotechnology | Q11468 |
| P304 | page(s) | e921040 | |
| P577 | publication date | 2020-03-22 | |
| P1433 | published in | Medical Science Monitor | Q15756323 |
| P1476 | title | Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review | |
| P478 | volume | 26 |
| Q102059013 | Ready-to-use nanopore platform for the detection of any DNA/RNA oligo at attomole range using an Osmium tagged complementary probe | cites work | P2860 |
Search more.